Literature DB >> 8399360

Identification of hybrid-type carbohydrate chains on the light chain of human monoclonal antibody specific to lung adenocarcinoma.

H Tachibana1, K Seki, H Murakami.   

Abstract

The carbohydrate chains on the light chains of human monoclonal antibody HB4C5 reactive to human lung adenocarcinoma tissue have been characterized. The HB4C5 antibody consists of two kinds of light chains (30 kDa and 32 kDa). Each chain has different carbohydrates of varying molecular masses linked to the variable regions. The 30 kDa light chain has been confirmed to be the active species for antibody binding. The carbohydrates on the light chains were characterized by lectin blot analysis combined with glycosidase treatment. A carbohydrate chain linked to the active 30 kDa light-chain species, and one of a few carbohydrate phenotypes on the 32 kDa light-chain species is characterized as "hybrid type". A sialylated complex-type carbohydrate could also bind to the 32 kDa light-chain species. Nucleotide sequence analysis revealed that one potential N-glycosylation site is located in the complementarity determining region 1 of the light chain, although no such site was found in the variable region of the heavy chain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399360     DOI: 10.1016/0925-4439(93)90067-b

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Concanavalin A stimulation enhanced secondary VlambdaJlambda rearrangement in some human plasma B cells without up-regulation of recombination-activating gene expression and Vlambda germline transcription.

Authors:  H Haruta; H Tachibana; K Yamada
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

2.  Building high affinity human antibodies by altering the glycosylation on the light chain variable region in N-acetylglucosamine-supplemented hybridoma cultures.

Authors:  H Tachibana; J Y Kim; S Shirahata
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

3.  Availability of oncogene activated production system for mass production of light chain of human antibody in CHO cells.

Authors:  T Miura; Y Katakura; P Seto; Y Zhang; K Teruya; E Nishimura; M Kato; S Hashizume; S Shirahata
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

4.  Further investigation of the light chain shifting phenomenon: light chain replacement through secondary rearrangement induced by lectin stimulation in the hybridoma cell line HB4C5.

Authors:  C Krungkasem; K Ueda; H Tachibana; S Shirahata
Journal:  Cytotechnology       Date:  1997       Impact factor: 2.058

5.  Modified antigen-binding of human antibodies with glycosylation variations of the light chains produced in sugar-limited human hybridoma cultures.

Authors:  H Tachibana; K Jiyoun; K Taniguchi; Y Ushio; K Teruya; K Osada; Y Inoue; S Shirahata; H Murakami
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-03       Impact factor: 2.416

6.  Glycosylation of antibody in a lectin-resistant human hybridoma is insensitive to glucose.

Authors:  H Tachibana; Y Ushio; H Murakami
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-04       Impact factor: 2.416

7.  Improvement of antigen binding ability of human antibodies by light chain shifting.

Authors:  T Siripen; H Tachibana; Y Katakura; S Shirahata
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

8.  Changes of monosaccharide availability of human hybridoma lead to alteration of biological properties of human monoclonal antibody.

Authors:  H Tachibana; K Taniguchi; Y Ushio; K Teruya; K Osada; H Murakami
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.